| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0306 |
| Document Type: 4 |
| Period of Report: 4/7/21 |
| Not Subject to Section 16: 0 |
| Issuer: |
| Issuer CIK: 1690080 |
| Issuer Name: 180 Life Sciences Corp. |
| Issuer Trading Symbol: ATNF |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1832327 |
| | Owner Name: Feldmann Marc |
| Reporting Owner Address: |
| | Owner Street 1: 830 MENLO AVENUE, SUITE 100 |
| | Owner Street 2: |
| | Owner City: MENLO PARK |
| | Owner State: CA |
| | Owner ZIP Code: 94025 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? Yes |
| | Is Officer? No |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: |
| | Other Text: |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 4/7/21 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | | Footnote ID: F1 |
| | Transaction Timeliness: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 20,910 |
| | | Transaction Price Per Share: |
| Value: 6.14 |
| Footnote ID: F1 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 2,617,758 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: Issued in consideration for accrued compensation due for services rendered as Co-Executive Chairman of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3. |
| Owner Signature: |
| Signature Name: /s/ Sir Marc Feldmann, Ph.D. |
| Signature Date: 4/9/21 |
